Doing the Right Right Thing, and Doing it Better: A Life Sciences Primer on ESG
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
Tag Archive for: life sciences
Covid-19: The Industry Response – How Are we Doing?
Chair: Clive Cookson, Science Editor, Financial Times Sean Marett, Chief Business and Chief Commercial Officer, BioNTech Professor James Logan, Head of Department of Disease Control, London School of Hygiene and Tropical Medicine Kate Bingham, Chair of UK Vaccine Taskforce & Managing Partner of SV Health Investors Rajeev Venkayya, MD, President Global Vaccine Business Unit, Takeda […]
Strengthening Our United Kingdom of Life Sciences
For the UK to fulfill its international aspirations, tapping into the soft power of its influential diaspora, including the 3,000+ life science leaders within the British Educated Life Scientists (BELS) global community, should be a high priority for UK organisations across our sector—government, quasi-government orgs, industry, academia, charities, healthcare orgs, service providers, incubators, investors, etc. Soft power […]
